Patents by Inventor Ann C. Sullivan

Ann C. Sullivan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thromboxane synthase inhibitors as insulin lowering agents and antiobesity agents
    Patent number: 4731363
    Abstract: The present disclosure relates to the use of thromboxane synthase inhibitors as antiobesity agents and insulin lowering agents. Such compounds fall into a variety of classes among which are 1-substituted imidazoles, 4-substituted imidazoles, 3-substituted pyridines, 3-substituted indoles, 4-substituted pyrimidines, 5-substituted tetrazoles, pyrazolidines, quinazolines, and substituted xanthene carboxylic acids.
    Type: Grant
    Filed: January 16, 1986
    Date of Patent: March 15, 1988
    Assignee: Hoffmann-La Roche Inc.
    Inventors: James G. Hamilton, Ann C. Sullivan, Lawrence D. Tobias, Joseph Triscari
  • Thromboxane synthase inhibitors as antiobesity agents
    Patent number: 4591594
    Abstract: The present disclosure relates to the use of thromboxane synthase inhibitors as antiobesity agents and insulin lowering agents. Such compounds fall into a variety of classes among which are 1-substituted imidazoles, 4-substituted imidazoles, 3-substituted pyridines, 3-substituted indoles, 4-substituted pyrimidines, 5-substituted tetrazoles, pyrazolidines, quinazolines, and substituted xanthene carboxylic acids.
    Type: Grant
    Filed: December 12, 1984
    Date of Patent: May 27, 1986
    Assignee: Hoffmann-La Roche Inc.
    Inventors: James G. Hamilton, Ann C. Sullivan, Lawrence D. Tobias, Joseph Triscari
  • Thromboxane synthase inhibitors as insulin lowering agents and antionbesity agents
    Patent number: 4500540
    Abstract: The present disclosure relates to the use of thromboxane synthase inhibitors as antiobesity agents and insulin lowering agents. Such compounds fall into a variety of classes among which are 1-substituted imidazoles, 4-substituted imidazoles, 3-substituted pyridines, 3-substituted indoles, 4-substituted pyrimidines, 5-substituted tetrazoles, pyrazolidines, quinazolines, and substituted xanthene carboxylic acids.
    Type: Grant
    Filed: June 11, 1982
    Date of Patent: February 19, 1985
    Assignee: Hoffmann-La Roche Inc.
    Inventors: James G. Hamilton, Ann C. Sullivan, Lawrence D. Tobias, Joseph Triscari
  • Chlorocitric acids
    Patent number: 4443619
    Abstract: The present invention relates to chlorocitric acids of the formula ##STR1## and stereoisomers, optical antipodes and pharmaceutically acceptable salts thereof, to methods of preparation thereof, including intermediates involved therein, and to their use as anorectic agents for the treatment of obesity in mammals.
    Type: Grant
    Filed: August 7, 1981
    Date of Patent: April 17, 1984
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Robert W. Guthrie, Richard W. Kierstead, Francis A. Mennona, Ann C. Sullivan
  • Chlorocitric acids
    Patent number: 4365070
    Abstract: The present invention relates to chlorocitric acids of the formula ##STR1## and stereoisomers, optical antipodes and pharmaceutically acceptable salts thereof, to methods of preparation thereof, including intermediates involved therein, and to their use as anorectic agents for the treatment of obesity in mammals.
    Type: Grant
    Filed: October 16, 1981
    Date of Patent: December 21, 1982
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Robert W. Guthrie, Richard W. Kierstead, Francis A. Mennona, Ann C. Sullivan
  • Chlorocitric acids
    Patent number: 4354039
    Abstract: The present invention relates to chlorocitric acids of the formula ##STR1## and stereoisomers, optical antipodes and pharmaceutically acceptable salts thereof, to methods of preparation thereof, including intermediates involved therein, and to their use as anorectic agents for the treatment of obesity in mammals.
    Type: Grant
    Filed: September 21, 1981
    Date of Patent: October 12, 1982
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Robert W. Guthrie, Richard W. Kierstead, Francis A. Mennona, Ann C. Sullivan
  • Chlorocitric acids
    Patent number: 4352758
    Abstract: The present invention relates to chlorocitric acids of the formula ##STR1## and stereoisomers, optical antipodes and pharmaceutically acceptable salts thereof, to methods of preparation thereof, including intermediates involved therein, and to their use as anorectic agents for the treatment of obesity in mammals.
    Type: Grant
    Filed: August 7, 1981
    Date of Patent: October 5, 1982
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Robert W. Guthrie, Richard W. Kierstead, Francis A. Mennona, Ann C. Sullivan
  • Process for making chlorocitric acid
    Patent number: 4340754
    Abstract: The present invention relates to chlorocitric acids of the formula ##STR1## and stereoisomers, optical antipodes and pharmaceutically acceptable salts thereof, to methods of preparation thereof, including intermediates involved therein, and to their use as anorectic agents for the treatment of obesity in mammals.
    Type: Grant
    Filed: September 21, 1981
    Date of Patent: July 20, 1982
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Robert W. Guthrie, Richard W. Kierstead, Francis A. Mennona, Ann C. Sullivan
  • Chlorocitric acids
    Patent number: 4312885
    Abstract: The present invention relates to chlorocitric acids of the formula ##STR1## and stereoisomers, optical antipodes and pharmaceutically acceptable salts thereof, to methods of preparation thereof, including intermediates involved therein, and to their use as anorectic agents for the treatment of obesity in mammals.
    Type: Grant
    Filed: December 26, 1978
    Date of Patent: January 26, 1982
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Robert W. Guthrie, Richard W. Kierstead, Francis A. Mennona, Ann C. Sullivan